
Evidence analysis
Alignment-Free Tool for Assemblies and Reads in Genomic Surveillance of Tuberculosis
Privacy & Data in Genomic Surveillance: Evidence Dossier on Alignment-Free Tuberculosis Genomic Tools Source: Emerging Infectious Diseases Journal, October 18, 2026. Article: Alignment-Free Tool for Assemblies and Reads in Genomic Surveillance of Tuberculosis, by P. Ruiz-Rodriguez and M.…
Read →
Evidence analysis
Associations of major congenital anomalies, long-term health conditions, and socioeconomic deprivation with educational attainment in Wales: A population-based data linkage study
What is established Educational attainment significantly influences life opportunities, including employment and social outcomes. Children’s educational success is known to be affected by health conditions, disabilities, and socioeconomic factors. Major congenital anomalies (MCAs)—structural or functional birth defects—affect a…
Read →
Evidence analysis
Designing for world in flux
Evidence Dossier: Designing Infrastructure in a Time of Flux What is established Infrastructure traditionally connotes permanence and stability, serving as the foundational framework supporting social, economic, and environmental life in cities. Classic examples of infrastructure include bridges, roads,…
Read →
Evidence analysis
How to know if you’re wrong
What is established Humans often hold beliefs with varying degrees of certainty, and it is common that some of these beliefs may be mistaken. Psychological and philosophical research recognizes that individuals have limited capacity to fully assess their…
Read →
Evidence analysis
Persistent Microfilaremia Caused by Dirofilaria asiatica Infection in Child, Sri Lanka, 2024
What is established Filarial nematodes are parasitic worms responsible for significant human diseases globally, especially in tropical regions. Several species, such as Wuchereria bancrofti and Brugia spp., cause lymphatic filariasis, while others produce subcutaneous or ocular filariases. The…
Read →
Evidence analysis
Fatal Rickettsia parkeri Rickettsiosis in Immunocompromised Pediatric Patient, Georgia, USA, 2025
Evidence Dossier: Fatal Rickettsia parkeri Rickettsiosis in Immunocompromised Pediatric Patient Fatal Rickettsia parkeri Rickettsiosis in an Immunocompromised Pediatric Patient: Evidence Dossier This dossier summarizes and assesses the evidence from a 2026 case report published in the Emerging Infectious…
Read →
Evidence analysis
Post–COVID-19 Expansion of Streptococcus pyogenes Lineages Causing Toxic Shock Syndrome, Japan, 2023–2024
Evidence Dossier: Expansion of Streptococcus pyogenes Lineages Causing Toxic Shock Syndrome in Post-COVID-19 Japan What is established Streptococcus pyogenes, specifically group A Streptococcus (GAS), is known to cause streptococcal toxic shock syndrome (STSS), a rapidly progressing and often…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Idefirix, imlifidase, Date of authorisation: 25/08/2020, Revision: 11, Status: Authorised
What is established Idefirix (active substance: imlifidase) is a medicine authorised in the European Union to aid kidney transplantation in adults who are highly sensitised and therefore at high risk of rejecting a donor kidney. It works by…
Read →
Evidence analysis
Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, Date of authorisation: 09/12/2021, Revision: 21, Status: Authorised
Evidence Dossier: Cibinqo (abrocitinib) for Atopic Dermatitis What is established Cibinqo, containing the active substance abrocitinib, is a medicine authorised in the European Union since December 2021 for the treatment of moderate to severe atopic dermatitis (eczema) in…
Read →
Evidence analysis
Communicable disease threats report, 10 – 16 October, week 42
Health & Science Evidence Dossier: Communicable Disease Threats in Europe, 10 - 16 October 2026 This dossier summarizes information from the European Centre for Disease Prevention and Control’s (ECDC) weekly Communicable Disease Threats Report (CDTR) for week 42…
Read →